Translational Glycomics Center located at Versiti’s Blood Research Institute in Milwaukee, Wisconsin
Safety Plan
Versiti Wisconsin, the Versiti Blood Research Institute and the conference organizers of the Translational Glycomics Symposium are committed to providing safe and just working and learning environments for all speakers, staff, sponsors, and attendees. Versiti and its subsidiaries holds the pursuit of enhanced well-being, dedication to excellence, and commitment to serving others at the center of our Mission, Vision, and Values. Also guided by Our Core Values, we are devoted to unwavering stewardship, inclusivity, and collaboration. Versiti’s commitment to maintaining a safe and supportive environment starts with its hiring practices as outlined by the Equal Employment Opportunity policy, which states:
“It is our policy to provide equal employment opportunity and to ensure that we do not unlawfully discriminate against any qualified employee or applicant on the basis of race, color, creed, religion, sex, age, marital status, national origin, citizenship, physical or mental disability, veteran status, or sexual orientation. Individuals with supervisory responsibilities must ensure that discriminatory motives do not impact job related decisions, and even the appearance of such motives should be steadfastly avoided. In addition, we will not tolerate unlawful discrimination against our employees by any business partner, or its employees, agents or contactors. If you believe you have been subjected to unlawful discrimination, please contact the Chief Human Resource Officer or the Chief Compliance Officer as soon as possible.”
Employees, business partners, sponsors, vendors, program attendees and speakers (including this event), and all other Versiti representatives must comply with the Versiti Code of Conduct, and the Non-Discrimination and Anti-Harassment Policy, which states:
“Versiti believes in the value of a diverse and inclusive workforce. We are committed to maintaining a work environment in which all individuals are treated with respect and dignity in a professional atmosphere. Accordingly, we are committed to enforcing this policy to create an environment free from discrimination, harassment, and retaliation. We will not tolerate discrimination or harassment based on race, color, age, sex, religious creed, marital status, pregnancy, genetic information, medical condition, physical/mental disability, military or veteran status, or any other characteristic that is prohibited by law. Any employee found to have engaged in any form of discriminatory, harassing, or retaliative behavior during employment will be subject to appropriate disciplinary action, up to and including termination of employment. Such behavior violating this policy will not be tolerated. We comply with all applicable federal and state laws governing discrimination, harassment, and retaliation.”
Versiti policies and procedures are outlined by the Versiti Compliance Program and have been developed by senior leadership in accordance with Compliance Program Guidance published by the Office of Inspector General (OIG), U.S Department of Health and Human Services (HHS). Please review the following information regarding Versiti policies for the communication of practice and conduct, as well as how to report violations of these policies, how complaints are investigated, and protections provided to those who have concerns:
Versiti Mission, Vision, and Our Core Values
Versiti Diversity, Equity, & Inclusion
Guided by the Versiti Compliance program and the Versiti Code of Conduct, Versiti and its subsidiaries are committed to maintaining an environment that is free of harassment and intimidation. Any person that believes they have been discriminated against, or has a concern regarding possible unethical, improper, or illegal conduct by Versiti or an affiliate representative is encouraged to report the incident. Individuals who have questions, concerns or complaints related to harassment are encouraged to contact the conference organizer(s) or the HHS Office of Civil Rights.
Conference Organizers and their contact information:
Karin Hoffmeister, MD, Director of Translational Glycomics Center & Deputy Director and Senior Investigator, Versiti Blood Research Institute: khoffmeister@versiti.org
Renee Hill, MBA, Senior Manager, Translational Glycomics Center, Versiti Blood Research Institute: rshill@versiti.org 414-937-3844
Anna Schmidt, Senior Coordinator, Translational Glycomics Center, Versiti Blood Research Institute: aschmidt@versiti.org 414-937-6858
Filing a complaint with the conference organizer is not required before filing a complaint of discrimination with HHS OCR, and seeking assistance from the conference organizer in no way prohibits filing complaints with HHS OCR: Filing a Civil Rights Complaint
Individuals can notify NIH about concerns of harassment, including sexual harassment, discrimination, and other forms of inappropriate conduct at NIH-supported conferences: https://grants.nih.gov/grants/policy/harassment/find-help.htm
Any person may also report concerns or misconduct as outlined by the Versiti Whistleblower Policy. This policy offers whistleblower protections in the form of confidentiality, anonymity, and the strict prohibition of retaliation.
Anonymous Hotline Contact Information:
Telephone: 213-443-1186
Internet: www.fulcrum.com/bcw
Email: whistle@fulcrum.com
U.S. mail: Fulcrum Inquiry
Whistleblower Department
888 S Figueroa Street, Suite 2000
Los Angeles, CA 90017
Fax: 213-891-1300
Versiti is committed to the highest standards of ethical and professional conduct. Versiti’s Chief Legal & Compliance Officer is required to coordinate a full investigation of all reported concerns, in conjunction with other leadership team members and the Audit & Compliance Committee. Appropriate corrective or disciplinary actions, up to and including termination of employment or termination of business relationship, and/or expulsion from all Symposium events will be undertaken for those individuals who have been found in violation of any of these applicable policies and practices.
"Funding for this conference was made possible (in part) by 1R13HL176037-01 from the National Heart Lung and Blood Institute (NHLBI). The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government."